Two-year observational study of deferiprone in superficial siderosis

[featured_image]
Deferiprone Study
Download is available until [expire_date]
  • Version 12.2017
  • Download 382
  • File Size 633.45 KB
  • File Count 1
  • Create Date January 3, 2018
  • Last Updated November 3, 2020

Two-year observational study of deferiprone in superficial siderosis

INTRODUCTION:

Superficial siderosis is a rare, neurodegenerative disease caused by toxic accumulation of hemosiderin on the surface of the brain and the spinal cord, most commonly from chronic subarachnoid hemorrhage.

AIMS:

The aim of this study was to assess the clinical and radiological outcomes of superficial siderosis patients using deferiprone, a cell permeant iron chelator. Subjects obtained pre- and post-treatment brain MRIs and weekly laboratory tests. Osirix software was used to develop a method of quantifying hemosiderin deposition. Three-dimensional whole brain images of gradient echo images were rendered and compared by dividing the mean T2 hyperintensity to the maximal cerebrospinal fluid signal.

Back to top button